Congressional Letter on use of Bayh-Dole Act to Control Drug Prices
February 22, 2024
A letter signed by 28 members of Congress urging President Biden to reconsider a NIST proposal to use the Bayh-Dole Act to "march in," weaken patents and exert federal control over prescription drug prices.
Download Full Comments Below
Congressional letter to the President on march-in rights
A letter signed by 28 members of Congress to President Biden urging reconsideration of a NIST proposal to use the Bayh-Dole Act to "march in" and control drug prices.
Dear Mr. Thune, Mr. Schumer, Mr. Johnson, and Mr. Jeffries:As President and CEO of the Biotechnology Innovation Organization (BIO), as a father and entrepreneur whose family is here today because of biotech innovation, and on behalf of the more than…
A letter signed by 28 members of Congress urging President Biden to reconsider a NIST proposal to use the Bayh-Dole Act to "march in," weaken patents and exert federal control over prescription drug prices.
A letter signed by 28 members of Congress to President Biden urging reconsideration of a NIST proposal to use the Bayh-Dole Act to "march in" and control drug prices.